Company intelligence / Profile preview

Bako Diagnostics

Alpharetta, Georgia, USAbakodx.com ↗

Ownership: Private
Employees: ~259
Development stage: Commercial

Overview

Provides commercial diagnostic and therapeutic solutions focused on podiatric medicine, including advanced molecular diagnostics for nail/skin conditions, neuropathy analysis via ENFD, and rapid pathogen identification. No clinical trial pipeline as it operates as a service provider.

Therapeutic areas: DermatologyNeurologyInfectious Diseases
Modalities: Diagnostic testing (Anatomic pathology)Molecular DNA testing (PCR-based diagnostics)Microbiology testingImmunohistochemistryMass spectrometry for bacterial identification
Industry: Molecular Diagnostics

Partnerships

In-network with all five national health plans and over two hundred additional insurance providers; no major pharma/biotech R&D partnerships disclosed

Beyond the preview

Go deeper on Bako Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bako Diagnostics.

Explore the full profile